© 2025 Lakeshore Public Media
8625 Indiana Place
Merrillville, IN 46410
(219)756-5656
Public Broadcasting for Northwest Indiana & Chicagoland since 1987
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Defunded but not defeated. Your support is essential. Donate now.

White House strikes new deals to lower prices on obesity drugs for some

By Sydney Lupkin
Published November 7, 2025 at 3:56 AM CST

The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.

Copyright 2025 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
See stories by Sydney Lupkin